Open AccessIn Reply
Author(s) -
Peled Nir
Publication year - 2015
Publication title -
the oncologist
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.176
H-Index - 164
eISSN - 1549-490X
pISSN - 1083-7159
DOI - 10.1634/theoncologist.2015-0157
Subject(s) - medicine , incidence (geometry) , cohort , immunohistochemistry , oncology , optics , physics
The letter stresses that the study under discussion aims to emphasize the obstacles in technology rather than provide incidence of ALK + in the cohort. The letter also reiterates the effectiveness of immunohistochemistry screening for ALK, followed by next‐generation sequencing for the borderline cases.